Cadrenal TherapeuticsCVKD
13F holders, Q2 2025 (June 30)3holders
0new positions
0sold out
$12.04avg. 13F price*
At the end of Q2 2025, 3 institutions reported holding Cadrenal Therapeutics Inc. (CVKD) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holders were Farther Finance Advisors, LLC ($301), Carolina Wealth Advisors, LLC ($241) and Caldwell Sutter Capital, Inc. ($60).
- Company
- Cadrenal Therapeutics Inc.
- CUSIP
- 127636108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 3 holders
| Farther Finance Advisors, LLC | 0.00% | No change | 25 | $301 |
| Carolina Wealth Advisors, LLC | 0.00% | No change | 20 | $241 |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 5 | $60 |
"% of holder's portfolio" is CVKD's weight in each manager's 13F, not the share of Cadrenal Therapeutics Inc. the manager owns.